Skip to main content
. 2022 Jul 28;13:968729. doi: 10.3389/fimmu.2022.968729

Figure 6.

Figure 6

In different ATB windows, the subgroup analysis between ATB use and OS of cancer patients treated with ICIs. (A) ATB window (−30 days, 0 day); (B) ATB window (−30 days, 30 days); (C) ATB window (−60 days, 0 days); (D) ATB window (−60 days, 30 days); and (E) ATB window (0 days, 30 day).